People on the Move
Sanofi
Belgian biotech Galapagos has hired Bart Filius, VP of Sanofi Europe, as its Chief Financial Officer (CFO).
Filius will join the company’s Executive Committee this December and will be responsible for Finance, Investor Relations, IT, and Purchasing.
He has worked for 13 years at Sanofi, including the past three as CFO of Sanofi Europe, and before that as country manager of Sanofi in the Netherlands, and VP of Mergers and Acquisitions.
Filius is a Dutch national and studied at Nyenrode University.
Galapagos develops drugs with novel modes of action, and has a pipeline of compounds at Phase II and earlier for cystic fibrosis, inflammation, antibiotics and metabolic disease. The company has a development deal with AbbVie for GLPG0634, a selective JAK1 inhibitor for inflammatory diseases.